Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily

被引:41
作者
Roehrborn, Claus G. [1 ]
Rosen, Raymond C. [2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[2] New England Res Inst, Watertown, MA 02172 USA
关键词
alfuzosin; lower urinary tract symptoms; benign prostatic hyperplasia; aging; cardiovascular system; sexual function;
D O I
10.2147/CIA.S3635
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are common in aging men and can significantly affect quality of life. Men with bothersome LUTS/BPH often present with various other age-related conditions, including sexual dysfunction, heart disease, hypertension, diabetes, and the metabolic syndrome, which can complicate management decisions. Therefore, healthcare providers should be familiar with first-line treatment options for LUTS/BPH and their differing safety profiles, particularly with respect to cardiovascular and sexual function side effects. This article presents a review of first-line medical therapy options for managing aging men with LUTS/BPH and patient considerations when evaluating and selecting these therapies, with a focus on the clinical efficacy and cardiovascular and sexual function safety profiles of the uroselective alpha(1)-adrenergic receptor antagonist alfuzosin 10 mg once daily. Alfuzosin improves LUTS, peak urinary flow rates, and disease-specific quality of life, reduces the long-term risk of overall BPH progression, and is well tolerated in aging men, with minimal vasodilatory and sexual function side effects, even in those with comorbidities. Alfuzosin is well tolerated when used in combination with antihypertensive medications and phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. The long-term clinical efficacy and good cardiovascular and sexual function safety profile of alfuzosin can contribute to an improved quality of life for aging men with LUTS/BPH.
引用
收藏
页码:511 / 524
页数:14
相关论文
共 85 条
[81]   Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction [J].
Van Moorselaar, RJA ;
Hartung, R ;
Emberton, M ;
Harving, N ;
Matzkin, H ;
Elhilali, M ;
Alcaraz, A ;
Vallancien, G .
BJU INTERNATIONAL, 2005, 95 (04) :603-608
[82]  
Viagra&REG
[83]  
, 2006, VIAGR SILD CITR TABL
[84]   Quality-of-life impact of lower urinary tract symptom severity: Results from the health professionals follow-up study [J].
Welch, G ;
Weinger, K ;
Barry, MJ .
UROLOGY, 2002, 59 (02) :245-250
[85]  
Yassin A, 2003, INT J IMPOT RES, V15, pS4